Neurosoft Bioelectronics raises USD 7.5 M

Neurosoft Bioelectronics develops flexible, stretchable brain-machine interfaces that have already been tested in 10 patients. It has raised USD 7.5 million in seed funding led by Skybound Venture Capital, with the aim of a first commercial launch in the United States.

Announced on
Round
Seed
Amount
USD 7.5 M
Location
Geneva
Sector
Health & medtech, Deep tech

Investors

  • Skybound Venture Capital lead
  • Protocol Labs
  • IAG Capital Partners
  • Connecticut Innovations

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic